Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958017 · ClinicalTrials.gov registry record · NA
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
A NA study of Stimulant Use Disorder and People Living With HIV, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05958017 is a NA study of Stimulant Use Disorder and People Living With HIV that is actively recruiting participants, run by University of Miami. The registered enrollment target is 500 participants, above the 155-participant average among 9 other Stimulant Use Disorder trials with a reported enrollment target (223% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05958017, a NA study of Stimulant Use Disorder and People Living With HIV, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Conditions Studied
Interventions
- BEHAVIORAL reSET
- OTHER Standard of care
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-03-04 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05958017
The ClinicalTrials.gov registry entry for NCT05958017 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 155-participant average among 9 other Stimulant Use Disorder trials with a reported enrollment target (223% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stimulant Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which reSET is the first listed.
NCT05958017 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05958017 about?
NCT05958017 is a clinical study titled "reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)". The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
What is the current status of trial NCT05958017?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-03-04. Estimated completion is 2028-01-31.
What conditions does trial NCT05958017 study?
This clinical trial studies the following conditions: Stimulant Use Disorder, People Living With HIV, reSET.
What interventions are being tested in trial NCT05958017?
The interventions under investigation include: reSET (BEHAVIORAL), Standard of care (OTHER).
Who is sponsoring clinical trial NCT05958017?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05958017 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stimulant Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
RECRUITING · NA
-
Smartphone Services for Stimulant Use Disorder
RECRUITING · NA
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
ACTIVE NOT RECRUITING · NA
-
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
ACTIVE NOT RECRUITING · NA
-
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
RECRUITING · Phase 2
-
Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.